Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-03

Clinical Trial Update: Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on safety and efficacy of NPS 1776 for acute treatment of migraine headaches is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NPS 1776

Snippet

Sponsor: Shire | Conditions: Migraine Headache | Phase 2 | Status: COMPLETED